Evidence map›Paper›PMID 21365001›Full record

ArticlePloS one2011

Presynaptic NMDA receptors mediate IPSC potentiation at GABAergic synapses in developing rat neocortex.

Seena S Mathew, John J Hablitz

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Axo-axonic synapses: Diversity in neural circuit function.The Journal of comparative neurology · 2021
    Review
  6. Inhibitory Plasticity: From Molecules to Computation and Beyond.International journal of molecular sciences · 2020
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Reduction in Ventral Midbrain NMDA Receptors Reveals Two Opposite Modulatory Roles for Glutamate on Reward.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Seena S MathewDepartment of Neurobiology and Evelyn F McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
John J Hablitz
University of Alabama at Birmingham · US

Funding

Alabama Neuroscience Blueprint Core CenterP30NS057098 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SWEATT, JOHN DAVID · 2006 to 2010
$9.5M
UAB MENTAL RETARDATION RESEARCH CENTER (MRRC)P30HD038985 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BRENNER, MICHAEL · 2000 to 2012
$8.6M
UAB Neuroscience Core CenterP30NS047466 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STANDAERT, DAVID G. · 2005 to 2019
$8.5M
NEOCORTICAL EPILEPSY DURING DEVELOPMENTR01NS022373 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HABLITZ, JOHN J. · 1986 to 2011
$2.7M
Presynaptic NMDA receptors and GABA release in cortical dysplasiaR21NS063342 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HABLITZ, JOHN J. · 2008 to 2009
$349k
NICHD NIH HHS P30 HD038985NICHD NIH HHS P30-HD38985NINDS NIH HHS NS22373NINDS NIH HHS NS63342NINDS NIH HHS P30 NS047466NINDS NIH HHS P30 NS057098NINDS NIH HHS P30-NS47466NINDS NIH HHS P30-NS57098NINDS NIH HHS R01 NS022373NINDS NIH HHS R21 NS063342
6 · The paper itself

Abstract

backgroundNMDA receptors are traditionally viewed as being located postsynaptically, at both synaptic and extrasynaptic locations. However, both anatomical and physiological studies have indicated the presence of NMDA receptors located presynaptically. Physiological studies of presynaptic NMDA receptors on neocortical GABAergic terminals and their possible role in synaptic plasticity are lacking. METHODOLOGY/PRINCIPAL

findingsWe report here that presynaptic NMDA receptors are present on GABAergic terminals in developing (postnatal day (PND) 12-15) but not older (PND21-25) rat frontal cortex. Using MK-801 in the recording pipette to block postsynaptic NMDA receptors, evoked and miniature IPSCs were recorded in layer II/III pyramidal cells in the presence of AMPA/KA receptor antagonists. Bath application of NMDA or NMDA receptor antagonists produced increases and decreases in mIPSC frequency, respectively. Physiologically patterned stimulation (10 bursts of 10 stimuli at 25 Hz delivered at 1.25 Hz) induced potentiation at inhibitory synapses in PND12-15 animals. This consisted of an initial rapid, large increase in IPSC amplitude followed by a significant but smaller persistent increase. Similar changes were not observed in PND21-25 animals. When 20 mM BAPTA was included in the recording pipette, potentiation was still observed in the PND12-15 group indicating that postsynaptic increases in calcium were not required. Potentiation was not observed when patterned stimulation was given in the presence of D-APV or the NR2B subunit antagonist Ro25-6981. CONCLUSIONS/SIGNIFICANCE: The present results indicate that presynaptic NMDA receptors modulate GABA release onto neocortical pyramidal cells. Presynaptic NR2B subunit containing NMDA receptors are also involved in potentiation at developing GABAergic synapses in rat frontal cortex. Modulation of inhibitory GABAergic synapses by presynaptic NMDA receptors may be important for proper functioning of local cortical networks during development.

Indexed as

AnimalsAnimals, NewbornDizocilpine MaleateExcitatory Amino Acid Antagonistsgamma-Aminobutyric AcidInduced Pluripotent Stem CellsNeocortexNeuronal PlasticityPresynaptic TerminalsRatsReceptors, N-Methyl-D-AspartateReceptors, PresynapticSynapsesSynaptic TransmissionDizocilpine MaleateExcitatory Amino Acid Antagonistsgamma-Aminobutyric AcidReceptors, N-Methyl-D-AspartateReceptors, Presynaptic

Identifiers

PMID21365001
PMCPMC3041804
OpenAlexW2042017476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.